2025 Chronic Pain Market Outlook: Key Indicators Shaping Growth Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Chronic Pain Industry Market Size Be by 2025?
The market size for chronic pain has seen robust growth in the past few years, with predictions that it will surge from $78.79 billion in 2024 to $84.96 billion in 2025, with a compound annual growth rate (CAGR) of 7.8%. The key drivers of growth during the historical period include injury and trauma, surgical procedures, inflammatory conditions, nerve injuries and neuropathy, and the absence of effective therapies.

What's the Long-Term Growth Forecast for the Chronic Pain Market Size Through 2029?
In the next few years, the market for chronic pain is predicted to experience robust growth. It is expected to expand to reach a value of $117.74 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 8.5%. Reasons contributing to this growth in the projected timeframe include an aging population, the proliferation of telemedicine, increased public health awareness, advances in genetic research and precision medicine, and psychosocial stressors. Significant trends during this forecast period are anticipated to involve the incorporation of wearable tech devices, the promotion of pain education and supportive communities, comprehensive pain management approaches, non-opioid pain control methods, and the use of regenerative medicine for pain.

View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

What Are the Key Growth Drivers Fueling the Chronic Pain Market Expansion?
The chronic pain market is predicted to expand due to the increasing number of individuals suffering from persistent pain. These individuals, known as chronic pain patients, experience discomfort that lasts beyond the usual healing period or lingers for a typically over three months. This high incidence of chronic pain fuels the expansion of the market, spurred by the growing necessity for effective pain management strategies, such as pharmaceuticals and medical devices. This also encourages industry innovation and development. For instance, the Australian Institute of Health and Welfare reported in June 2024 that an estimated 4.0 million Australians, or 16% of the population, were dealing with back problems in 2022. By 2023, back ailments had become the third most significant cause of disease burden, making up 4.3% of the country's overall disease load. Additionally, in February 2024, the Institute for Health Metrics and Evaluation, a US-based domestic and international public health and research agency, published another report projecting globally about 269 million cases of neck pain by 2050, showing an increase of 32.5% (between 23.9% and 42.3%) when compared to 2020. Therefore, the increasing prevalence of chronic pain is the driving force behind the growth of the chronic pain market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp

What Are the Key Trends Driving Chronic Pain Market Growth?
The chronic pain market is experiencing a surge in popularity for alternative pain relief methods, driven largely by advancements in technology. Firms within the market are honing their focus on the creation of innovative handheld and user-oriented nerve stimulation tools. These tools utilize electrical impulses to activate nerves and ease pain, providing users with a non-invasive substitute for traditional pain management methods. To solidify its presence in the market, Abbott Laboratories, an American health service company renowned for its work in diagnostics, medical devices, nutrition, and proprietary generic pharmaceuticals, introduced a cutting-edge spinal cord stimulation (SCS) system called Eterna in December 2022. Currently, the device is regarded as the most diminutive, implantable, rechargeable product available in the chronic pain treatment industry. Eterna SCS leverages unique low-dose BurstDR stimulation from Abbott, the only waveform technology supported by extensive clinical evidence (1A evidence). It has shown a 23% higher reduction in pain compared to conventional waveform technology strategies.

How Is the Chronic Pain Market Segmented?
The chronic pain market covered in this report is segmented -

1) By Product: Drug, Devices
2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications
3) By End User: Hospitals, Clinics, Research Organization

Subsegments:
1) By Drug: Non-Opioid Analgesics, Opioids, Antidepressants, Anticonvulsants, Topical Analgesics, Corticosteroids
2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units, Spinal Cord Stimulators, Intrathecal Drug Delivery Systems, Heat And Cold Therapy Devices, Bioelectronic Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11970&type=smp

Which Companies Are Leading the Charge in Chronic Pain Market Innovation?
Major companies operating in the chronic pain market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

Which Regions Are Leading the Global Chronic Pain Market in Revenue?
North America was the largest region in the chronic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11970

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.